[HTML][HTML] Nonhuman adenoviral vector-based platforms and their utility in designing next generation of vaccines for infectious diseases
Several human adenoviral (Ad) vectors have been developed for vaccine delivery owing to
their numerous advantages, including the feasibility of different vector designs, the …
their numerous advantages, including the feasibility of different vector designs, the …
[HTML][HTML] A case report of immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination
G Kim, EJ Choi, HS Park, JH Lee… - Journal of Korean …, 2021 - synapse.koreamed.org
Immune thrombocytopenia (ITP) is an autoimmune condition characterized by platelet
destruction through antibody-mediated mechanism. ITP is one of the manifestations of a …
destruction through antibody-mediated mechanism. ITP is one of the manifestations of a …
Zašto neki političari, novinari i zdravstveni djelatnici zagovaraju cijepljenje djece protiv covid-19?
P Gabrić - 2021 - osf.io
U hrvatskim je medijima sve više govora o cijepljenju djece protiv covid-19, unatoč maloj
ulozi djece u prijenosu novog koronavirusa i njihovom malom riziku od teških simptoma …
ulozi djece u prijenosu novog koronavirusa i njihovom malom riziku od teških simptoma …
新型コロナウイルスワクチン投与後に発症した重篤な血小板減少症
萩原政夫， 内田智之， 井上盛浩， 大原慎， 今井唯 - 臨床血液, 2021 - jstage.jst.go.jp
抄録 免疫性血小板減少性紫斑病 (ITP) 症例における新型コロナウイルス (SARS-CoV-2)
ワクチン後の血小板減少は, 日本血液学会から勧告されている重要な注意事項である. 一方, SARS …
ワクチン後の血小板減少は, 日本血液学会から勧告されている重要な注意事項である. 一方, SARS …